The Biden administration wants to be able to make enough vaccine to cover the entire country within 130 days of a pandemic pathogen emerging, and the plan calls for repurposing existing drugs into treatments within 90 days or inventing new treatments in double that time.

A panel of FDA advisers on Wednesday (Oct. 19) overwhelmingly backed the agency’s proposal to pull Covis Pharma’s preterm birth drug Makena from the market -- a move that has implications for FDA’s accelerated approval pathway.